Illumina Inc
ILMN Real Time Price USDRecent trades of ILMN by members of U.S. Congress
---
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes in ILMN holdings by institutional investors
Quarterly net insider trading by ILMN's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More about Alpha -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More about Annual Standard Deviation -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More about Annual Volatility -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More about Beta -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More about CAGR -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More about Information Ratio -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More about Max Drawdown -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More about Sharpe Ratio -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More about Treynor Ratio -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
-
$300,000 Jul 20, 2026 Issue: Health Issues Homeland Security Medicare/Medicaid Trade (domestic/foreign)
-
$320,000 Apr 20, 2026 Issue: Budget/Appropriations Health Issues Homeland Security Medicare/Medicaid Trade (domestic/foreign)
-
$330,000 Jan 20, 2026 Issue: None
-
$380,000 Oct 20, 2025 Issue: Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$410,000 Jul 21, 2025 Issue: Budget/Appropriations Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$620,000 May 08, 2025 Issue: Budget/Appropriations Health Issues Homeland Security
-
$400,000 Jan 21, 2025 Issue: Budget/Appropriations Health Issues Defense
-
$280,000 Dec 12, 2024 Issue: Budget/Appropriations Defense Health Issues
-
$270,000 Jul 22, 2024 Issue: Defense Trade (domestic/foreign) Health Issues
-
$510,000 Jan 22, 2024 Issue: Defense Trade (domestic/foreign) Government Issues Health Issues
-
$420,000 Oct 20, 2023 Issue: Defense Trade (domestic/foreign) Government Issues Health Issues
-
$1,460,000 Jul 20, 2023 Issue: Defense Trade (domestic/foreign) Government Issues Health Issues
-
$1,300,000 Jan 20, 2023 Issue: Trade (domestic/foreign) Government Issues Health Issues
-
$1,380,000 Oct 20, 2022 Issue: Trade (domestic/foreign) Government Issues Health Issues
-
$1,690,000 Jul 20, 2022 Issue: Trade (domestic/foreign) Government Issues Health Issues
-
$1,960,000 Apr 20, 2022 Issue: Government Issues Health Issues
-
$820,000 Jan 20, 2022 Issue: Government Issues
-
$10,000 Jan 20, 2022 Issue: Government Issues
-
$60,000 Jan 20, 2022 Issue: Health Issues
-
$50,000 Jan 20, 2022 Issue: None
-
$40,000 Jan 20, 2022 Issue: Labor Issues/Antitrust/Workplace Medicare/Medicaid Health Issues
-
$50,000 Jan 20, 2022 Issue: Health Issues
-
$60,000 Jan 19, 2022 Issue: Health Issues
-
$320,000 Jan 19, 2022 Issue: Health Issues Government Issues
-
$10,000 Oct 28, 2021 Issue: Government Issues
-
$920,000 Oct 21, 2021 Issue: Government Issues
-
$60,000 Oct 20, 2021 Issue: Health Issues
-
$50,000 Oct 20, 2021 Issue: None
-
$40,000 Oct 20, 2021 Issue: Medicare/Medicaid Health Issues Labor Issues/Antitrust/Workplace
-
$10,000 Oct 19, 2021 Issue: Government Issues
-
$50,000 Oct 19, 2021 Issue: Health Issues
-
$375,000 Oct 18, 2021 Issue: Health Issues Government Issues
-
$20,000 Jul 29, 2021 Issue: Health Issues
-
$60,000 Jul 20, 2021 Issue: Health Issues Labor Issues/Antitrust/Workplace
-
$40,000 Jul 20, 2021 Issue: Labor Issues/Antitrust/Workplace Health Issues Veterans Medicare/Medicaid
-
$40,000 Jul 20, 2021 Issue: Government Issues
-
$150,000 Jul 19, 2021 Issue: Health Issues Government Issues
-
$50,000 Jul 19, 2021 Issue: Trade (domestic/foreign)
-
$290,000 Apr 20, 2021 Issue: None
-
$270,000 Jan 21, 2021 Issue: None
-
$270,000 Oct 20, 2020 Issue: None
-
$170,000 Jul 20, 2020 Issue: None
-
$180,000 Apr 20, 2020 Issue: HEALTH ISSUES
-
$190,000 Jan 21, 2020 Issue: None
-
$160,000 Oct 21, 2019 Issue: Budget/Appropriations Health Issues
-
$160,000 Jul 22, 2019 Issue: Budget/Appropriations Health Issues
-
$130,000 Apr 22, 2019 Issue: Health Issues Budget/Appropriations
-
$60,000 Jan 22, 2019 Issue: Health Issues
-
$60,000 Oct 22, 2018 Issue: Health Issues
-
$70,000 Jul 20, 2018 Issue: Health Issues
-
$100,000 Apr 20, 2018 Issue: Medicare/Medicaid Budget/Appropriations
-
$50,000 Jan 19, 2018 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid Budget/Appropriations
-
$50,000 Oct 20, 2017 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid Budget/Appropriations
-
$50,000 Jul 20, 2017 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations Medicare/Medicaid
-
$40,000 Apr 18, 2017 Issue: Medical/Disease Research/Clinical Labs
-
$45,000 Jan 13, 2017 Issue: Health Issues
-
$45,000 Oct 19, 2016 Issue: Health Issues
-
$60,000 Jul 20, 2016 Issue: Health Issues
-
$90,000 Apr 20, 2016 Issue: Health Issues
-
$20,000 Jan 20, 2016 Issue: Health Issues
-
$40,000 Jan 18, 2013 Issue: Homeland Security Science/Technology Defense
Former government officials who have lobbied for ILMN
24 former government officials from 18 congressional offices at 6 lobbying firms have lobbied for ILMN, most recently Jul 21, 2026.
-
Katherine Cotton House Staff Assistant, Legislative Correspondent, Legislative Assistant - U.S. Representative Brett Guthrie -
Paul Edattel House Chief Health Counsel, House Energy & Commerce Committee; Policy Assistant, Office of the Speaker; Professional Staff Member for the Majority at the House Energy & Commerce Committee; Legislative Assistant & Legislative Director, Rep. John Shadegg -
Daniel Todd Senate Senior Health Counsel, Senate Finance Committee; Special Assistant, Office of Admin. Ct. - Medicare & Medicaid
-
Nicholas Uehlecke House Senior Advisor, Dept. of Health and Human Services; Professional Staff/Sr. Legislative Assistant, House Ways and Means Subcommittee
-
Keith Studdard House Legislative Director, Rep. Marsha Blackburn -
John Herzog Senate Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President -
John Ray House Legislative Assistant, Rep. Mike Kelly -
Laura Kemper Senate Counsel, Sen. John Cornyn; Deputy Assistant Secretary for Legislation, U.S. Department of Health and Human Services; Counselor to the Secretary, U.S. Department of Health and Human Services
ILMN Estimated quarterly lobbying spending
ILMN Revenue by Segment or Geography
New ILMN patent grants
-
Patent Title: Compensator for multiple surface imaging Mar. 26, 2024
-
Patent Title: Cartridge label Sep. 26, 2023
-
Patent Title: Cartridge cover Sep. 19, 2023
-
Patent Title: Cartridge label Sep. 12, 2023
-
Patent Title: Cartridge label Sep. 12, 2023
-
Patent Title: Cartridge label Jul. 18, 2023
-
Patent Title: Cartridge chassis May. 23, 2023
-
Patent Title: Display screen or portion thereof with graphical user interface Mar. 14, 2023
-
Patent Title: Light visor for sequencing instrument Feb. 07, 2023
-
Patent Title: Cartridge label Jan. 24, 2023
-
Patent Title: Display screen or portion thereof with animated graphical user interface Dec. 13, 2022
-
Patent Title: Display screen or portion thereof with animated graphical user interface Dec. 06, 2022
-
Patent Title: Sequencing instrument Nov. 01, 2022
-
Patent Title: Sequencing instrument Oct. 18, 2022
-
Patent Title: Display screen with a graphical user interface Oct. 04, 2022
-
Patent Title: Fluidic system for reagent delivery to a flow cell Mar. 29, 2022
-
Patent Title: Compensator for multiple surface imaging May. 18, 2021
-
Patent Title: Compensator for multiple surface imaging Sep. 22, 2020
-
Patent Title: Polynucleotide modification on solid support Jun. 13, 2017
-
Patent Title: Modified polymerases for improved incorporation of nucleotide analogues Jun. 13, 2017
-
Patent Title: Microarray fabrication system and method Jun. 06, 2017
-
Patent Title: Haplotype resolved genome sequencing Jun. 06, 2017
-
Patent Title: Integrated optoelectronic read head and fluidic cartridge useful for nucleic acid sequencing May. 16, 2017
-
Patent Title: Methods and compositions for processing chemical reactions May. 16, 2017
-
Patent Title: Methods for selecting and amplifying polynucleotides Apr. 18, 2017
-
Patent Title: Tandem sequencing top and bottom strands of double stranded nucleic acid using arrays configured for single molecule detection Mar. 28, 2017
-
Patent Title: Functionalization and purification of molecules by reversible group exchange Mar. 21, 2017
-
Patent Title: Method of nucleic acid amplification Mar. 14, 2017
-
Patent Title: Compositions and methods for representational selection of nucleic acids from complex mixtures using hybridization Mar. 07, 2017
-
Patent Title: Sequencing by orthogonal synthesis Feb. 21, 2017
-
Patent Title: Solid-phase clonal amplification and related methods Feb. 21, 2017
-
Patent Title: Methods of nucleic acid sequencing Feb. 21, 2017
-
Patent Title: Array domains having rotated patterns Feb. 14, 2017
-
Patent Title: Optical alignment tool Jan. 10, 2017
-
Patent Title: Data processing system and methods Dec. 27, 2016
-
Patent Title: Gel patterned surfaces Dec. 06, 2016
-
Patent Title: Reducing adapter dimer formation Nov. 29, 2016
-
Patent Title: Formylpyrrole-based heterocycles for nucleic acid attachment to supports Oct. 25, 2016
-
Patent Title: Compositions and methods for nucleotide sequencing Oct. 18, 2016
-
Patent Title: Methods and compositions for nucleic acid sequencing Sep. 27, 2016
-
Patent Title: Cloud computing environment for biological data Sep. 13, 2016
-
Patent Title: Detection of nucleic acid reactions on bead arrays Sep. 13, 2016
-
Patent Title: Method of sequencing nucleic acid colonies formed on a surface by re-seeding Aug. 16, 2016
-
Patent Title: Compositions and methods for preparing oligonucleotide solutions Aug. 16, 2016
-
Patent Title: Devices and systems for creation of dna cluster arrays Aug. 16, 2016
-
Patent Title: Fluidic system for reagent delivery to a flow cell Aug. 09, 2016
-
Patent Title: Dynamic autofocus method and system for assay imager Aug. 02, 2016
-
Patent Title: Multiplex decoding of array sensors with microspheres Jul. 26, 2016
-
Patent Title: Flow cells for biological or chemical analysis Jul. 12, 2016
-
Patent Title: Massively parallel signature sequencing by ligation of encoded adaptors Jan. 10, 2012
Federal grants, loans, and purchases
- $263,541 2026-09-10 00:00:00 Agency: Department of Agriculture
- $242,235 2026-09-09 00:00:00 Agency: Department of Agriculture
- $203,948 2026-09-08 00:00:00 Agency: Department of Health and Human Services
- $49,655 2026-09-08 00:00:00 Agency: Department of Health and Human Services
- $79,678 2026-09-03 00:00:00 Agency: Department of Health and Human Services
- $311,132 2026-09-03 00:00:00 Agency: Department of Veterans Affairs
- $93,568 2026-09-01 00:00:00 Agency: Department of the Interior
- $53,443 2026-08-28 00:00:00 Agency: Department of Health and Human Services
- $16,106 2026-08-28 00:00:00 Agency: Department of Health and Human Services
- $119,216 2026-08-27 00:00:00 Agency: Department of Health and Human Services
- $49,352 2026-08-26 00:00:00 Agency: Department of Agriculture
- $96,859 2026-08-24 00:00:00 Agency: Department of Health and Human Services
- $199,336 2026-08-20 00:00:00 Agency: Department of Justice
- $65,531 2026-08-20 00:00:00 Agency: Department of Agriculture
- $61,428 2026-08-20 00:00:00 Agency: Department of Agriculture
- $311,813 2026-08-20 00:00:00 Agency: Department of Health and Human Services
- $97,164 2026-08-19 00:00:00 Agency: Department of Agriculture
- $15,810 2026-08-17 00:00:00 Agency: Department of Agriculture
- $49,655 2026-08-17 00:00:00 Agency: Department of Veterans Affairs
- $496,081 2026-08-12 00:00:00 Agency: Department of Health and Human Services
- $254,898 2026-08-11 00:00:00 Agency: Department of Veterans Affairs
- $117,574 2026-08-11 00:00:00 Agency: Department of Agriculture
- $70,066 2026-08-10 00:00:00 Agency: Department of Health and Human Services
- $25,349 2026-08-07 00:00:00 Agency: Environmental Protection Agency
- $22,874 2026-08-06 00:00:00 Agency: Department of Agriculture
- $36,426 2026-08-06 00:00:00 Agency: Department of Veterans Affairs
- $53,443 2026-08-05 00:00:00 Agency: Department of Agriculture
- $187,219 2026-08-05 00:00:00 Agency: Department of Health and Human Services
- $31,969 2026-08-05 00:00:00 Agency: Department of Health and Human Services
- $30,194 2026-08-03 00:00:00 Agency: Department of Health and Human Services
- $53,443 2026-07-27 00:00:00 Agency: Department of Agriculture
- $30,064 2026-07-27 00:00:00 Agency: Department of Agriculture
- $32,044 2026-07-23 00:00:00 Agency: Department of Health and Human Services
- $90,232 2026-07-22 00:00:00 Agency: Department of Health and Human Services
- $14,144 2026-07-22 00:00:00 Agency: Department of the Interior
- $44,035 2026-07-21 00:00:00 Agency: Department of Health and Human Services
- $15,810 2026-07-20 00:00:00 Agency: Department of Agriculture
- $99,922 2026-07-16 00:00:00 Agency: Department of Health and Human Services
- $120,573 2026-07-15 00:00:00 Agency: Department of the Interior
- $160,371 2026-07-14 00:00:00 Agency: Department of Health and Human Services
- $247,305 2026-07-14 00:00:00 Agency: Department of Health and Human Services
- $49,655 2026-07-13 00:00:00 Agency: Department of Health and Human Services
- $16,760 2026-07-09 00:00:00 Agency: National Aeronautics and Space Administration
- $39,168 2026-07-09 00:00:00 Agency: Department of Agriculture
- $143,975 2026-07-08 00:00:00 Agency: Department of Health and Human Services
- $99,994 2026-07-08 00:00:00 Agency: Department of Health and Human Services
- $250,498 2026-07-07 00:00:00 Agency: Department of Health and Human Services
- $24,031 2026-07-07 00:00:00 Agency: Department of Health and Human Services
- $26,738 2026-06-30 00:00:00 Agency: Department of Health and Human Services
- $411,752 2026-06-26 00:00:00 Agency: Department of Agriculture
Estimated quarterly amount awarded to ILMN from public contracts
Recent insights relating to ILMN
Recent picks made for ILMN stock on CNBC
ETFs with the largest estimated holdings in ILMN
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $ILMN stock a Buy, Sell, or Hold?
- What is the price target for $ILMN stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $ILMN stock?
- Who owns the most shares of $ILMN stock?
- What funds own $ILMN stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view ILMN Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
- Address San Diego, CA
- Market Cap 31.2 billion
- Employees 8,650
- Industrial Classification Laboratory Analytical Instruments
We estimate that -- received a compensation of -- in --, making them the highest paid executive at ILMN, per a recent SEC DEF 14A filing. We estimate that the median employee at ILLUMINA, INC. is paid $138,432.
|
Name
|
Role
|
Salary
|
Bonus
|
Stock/Option Awards
|
Total Compensation
|
|---|